Search PDMR transactions

Notifier
Name of person with notification obligation
Gustaf Albèrt
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Gustaf Albèrt
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
IRLAB Therapeutics AB
Issuer´s LEI code
549300JAT34LHEI0DH60
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
BTA IRLAB Therapeutics AB BTA A SE0029026145 Subscription 202,631 Quantity 1.20 SEK 03/07/2026 NASDAQ STOCKHOLM AB
Share IRLAB Therapeutics A SE0012675361 Subscription 97,369 Quantity 1.20 SEK 03/07/2026 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
IRLAB Therapeutics AB BTA A SE0029026145 Subscription 03/07/2026 NASDAQ STOCKHOLM AB 202,631 (Quantity) 1.20 SEK
IRLAB Therapeutics A SE0012675361 Subscription 03/07/2026 NASDAQ STOCKHOLM AB 97,369 (Quantity) 1.20 SEK
<< Back